Primary Glaucoma

Published on 08/03/2015 by admin

Filed under Opthalmology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2603 times

7 Primary Glaucoma

INTRAOCULAR PRESSURE

The concept of ‘normal’ IOP is based on a population survey in Europe where readings were assumed to be normally distributed and two standard deviations above the mean gave a normal upper limit of 21 mmHg, implying that only 2.5% of normal people would be expected to have ‘increased’ IOP. However, ‘normal’ IOP is not normally distributed but skewed to the right and as a result a greater proportion of the normal population has an IOP exceeding 21 mmHg than was predicted initially. This right skew increases with age and varies by race; for example, mean IOP in Japan is 11.6 mmHg but that in Barbados is 18.1 mmHg. IOP tends to be higher in older people. Measurement of IOP by methods that applanate the cornea (see Ch. 1) is affected by central corneal thickness which varies between people. The Goldmann applanation tonometer assumes a central corneal thickness of 520 μm; applanation underestimates IOP with thinner corneas and overestimates IOP with thicker corneas. As a rule increased corneal thickness of 10 μm artefactually increases the IOP by 1 mm and similarly underestimates IOP in thin corneas. This is of considerable importance after laser corneal refractive surgery. The factors that regulate IOP are those that alter the rate of aqueous production or outflow resistance.

AQUEOUS HUMOUR FORMATION AND OUTFLOW

Aqueous humour forms at a rate of 2–3μl/min during the day, the fluid volume of the anterior chamber being exchanged every 100 min. At night aqueous flow is approximately halved. Aqueous is formed by a combination of active and passive processes (diffusion and ultrafiltration). About 70 per cent of aqueous is actively secreted by the nonpigmented ciliary epithelium; sodium transport is crucial for this process. Although the ciliary epithelium itself does not have a neuronal supply blood vessels in the ciliary body are well endowed with sympathetic fibres through which drugs such as the sympathomimetics and β-blockers probably act. The mechanisms controlling aqueous secretion remain incompletely understood. There is no evidence, however, that the rate of aqueous production is increased in patients with POAG.

There are two routes of aqueous outflow: trabecular meshwork (conventional) and uveoscleral (nonconventional). Up to 90 per cent of aqueous outflow is through the trabecular meshwork and into Schlemm’s canal and the aqueous veins and is dependent on pressure. Increased resistance to outflow, because of age or disease, requires a higher ‘head’ of pressure to maintain the same throughput of fluid out of the eye resulting in a higher IOP. At least 50 per cent of resistance to outflow is located in the juxtacanalicular region of the trabecular meshwork and in POAG resistance to outflow in this region is thought to be abnormally high. Approximately 10 per cent of aqueous outflow is through the uveoscleral pathway although recent studies have suggested that outflow here may actually be much higher in the young. Aqueous flows through the interstitial spaces of the ciliary muscle into the supraciliary and suprachoroidal spaces and finally through the sclera or into the vortex veins. Uveoscleral flow is independent of pressure and decreases with age.

Table 7.2 lists the factors that potentially cause an increase in IOP; these include increased ciliary epithelial production of aqueous, an altered blood–retinal barrier and, more commonly, increased resistance of the conventional outflow channels. Table 7.3 shows factors that may cause a decrease in IOP: decreased aqueous production, structural alterations in the conventional outflow channels, and an increase in outflow by nonconventional routes.

PRIMARY OPEN ANGLE GLAUCOMA

PREVALENCE

POAG, or chronic simple glaucoma, is the most common form of glaucoma in the West. The median age-adjusted prevalence in people aged over 40 years taken from a number of population surveys is 1.6 per cent in Caucasians and 4.6 per cent in black people. Approximately 4 per cent of white people and 8 per cent of black people with glaucoma are bilaterally blind. Typically the onset is insidious and central visual acuity is not lost until the late stages of the disease. Most referrals follow opportunistic screening of the asymptomatic patient; alternatively patients present when both eyes become affected or coincidentally when the patient accidentally covers the ‘good’ eye and becomes aware of severe visual loss in the affected eye.

Considerable emphasis has been placed on screening the asymptomatic population as there is evidence that early treatment of the disease carries a better prognosis. The low overall prevalence of the disease means, however, that mass population screening is uneconomic and screening has to be restricted to higher risk groups. The major risk factors for glaucoma are raised IOP, older age and ethnic origin. Other risk factors include a positive family history, myopia, vascular disorders (systemic hypertension, nocturnal hypotension and vasospasm) and possibly diabetes. There is a continuous, exponential relationship between the level of IOP and risk of glaucoma. The prevalence of POAG also increases exponentially with age. Around 1 per cent of Caucasians aged 50 years have POAG, rising to 4 per cent in those aged 80 years. For black people, the respective values are 3 and 13 per cent.

Familial and genetic factors have been implicated in susceptibility to glaucoma but the mechanisms that lead to the development of glaucoma are not yet known. In some families the pattern of inheritance is autosomal dominant with reduced penetrance. The role of genes is complex; susceptibility is probably under multigenic influence and disease may not manifest without the presence of other risk factors. At present identified glaucoma genes account for fewer than 5 per cent of cases of primary glaucoma. The first glaucoma gene to be identified was the MYOC/TIGR gene which codes for the protein myocillin found in the trabecular meshwork and also in the ciliary body, retina and optic nerve head. Steroids induce the expression of myocilin in the trabecular meshwork. Other gene mutations and polymorphisms have been reported. For example, OPTN, which codes for a protein thought to be involved in the tumour necrosis factor (TNF) signalling pathway and OPA1, which codes for a dynamin guanosine triphosphatase involved in forming and maintaining the mitochondrial network have been implicated in normal-pressure glaucoma; GSTM1, which codes for glutathione S-transferase, may be associated with POAG.

PATHOGENESIS OF GLAUCOMA

Optic nerve damage

Loss of visual function in glaucoma results from retinal ganglion cell damage and death. There is some evidence that larger ganglion cell axons may be more susceptible to injury than small axons, although this is controversial. Ganglion cells with larger fibres subserve the functions of movement detection and contrast sensitivity (magnocellular pathway) and blue–yellow colour vision (koniocellular pathway). Those with small diameter fibres are responsible for acuity and red–green colour sense (parvocellular pathway). Tests that detect loss of contrast sensitivity, movement thresholds and blue–yellow colour vision are promising tools for earlier diagnosis.

The mechanisms underlying neuronal damage are still not fully elucidated and include mechanical deformation, vascular insufficiency and neurotoxic injury. These processes are not mutually exclusive and the final common pathway is thought to be ganglion cell apoptosis (cell death without inflammation).

Mechanical damage from raised IOP may be mediated in a number of ways. High pressure will distort the plates of the lamina cribrosa, compressing ganglion cell axons and blocking retrograde flow of neurotrophic factors to the ganglion cell body. Distortion of lamina plates may also disrupt capillaries that lie within the plates. Astrocytes, which provide physiological and structural support to ganglion cell axons and maintain the trabecular beams of the lamina cribrosa, may become dysfunctional resulting in disrupted axoplasmic transport, direct neurotoxicity (e.g. from nitric oxide or TNFα), and disruption of the extracellular matrix and cribosal plate architecture. The trabeculae of the lamina cribrosa are at the site of maximum mechanical stress in the eye. This is greater when the sclera is thinner, when the optic disc is larger (e.g. in highly myopic eyes), and at the vertical poles of the disc. Theoretically collagen or elastin may be structurally abnormal in some eyes making them more susceptible to IOP damage than others.

A vascular mechanism may have several components relating to systemic blood pressure (BP), local vascular damage and autoregulation. The concept of ‘perfusion pressure’ (mean BP minus IOP) is important in describing the potential effect of either raised IOP or low BP, particularly in the nocturnal hypotension that affects some patients. A primary vessel defect or poor autoregulation involving the short posterior ciliary arteries and the circle of Zinn–Haller that supply the laminar region (see Ch. 17) could cause local vascular insufficiency. Vascular insufficiency may directly damage neurones through ischaemia, hypoxia, or indirectly by activation of astrocytes.

ASSESSMENT OF THE EYE WITH PRIMARY OPEN ANGLE GLAUCOMA

Key components for assessment of the glaucomatous eye are: IOP measurement, gonioscopy, examination of the optic disc and retinal nerve fibre layer and visual field examination. The techniques of IOP measurement and gonioscopy are covered in Ch. 1.

Gonioscopy

In addition to the ‘openness’ of the angle, the profile of the iris approach to the angle should be noted, the amount and distribution of pigment in the angle and, if present, the extent of peripheral anterior synechiae. Spaeth’s grading describes the iris profile as steep, regular or concave, or as having a plateau configuration (anterior chamber deep centrally but shallow peripherally with a prominent peripheral roll of iris seen on indentation gonioscopy). In heavily pigmented eyes the peripheral iris may be particularly bulky and a cause of angle crowding and closure.

Table 7.4 describes angle grading, derived from Scheie and Shaffer.

Table 7.4 Angle grading (derived from Scheie and Shaffer)

Angle grade Angle width Description
4 35–45° Wide open
3 20–35° Open
2 20° Apex of angle not visible, scleral spur visible
1 10° Posterior half of meshwork not visible, spur not visible, Schwalbe’s line visible
0 No angle structures seen

Optic disc

The recognition of glaucomatous cupping is fundamental to a diagnosis of POAG. The normal appearance of the optic disc is governed by the size and shape of the optic nerve and by the angle it makes with the eye (disc tilt). Larger discs have larger physiological cups and the cup is more elliptical in elliptical discs. The optic disc is best examined by stereo-ophthalmoscopy with a high-power biconvex lens. Red-free photographs show retinal nerve fibre detail more clearly. As with any chronic disease producing gradual change, a transition phase occurs between the optic disc appearing merely ‘suspicious’ to ‘typically glaucomatous’.

Imaging technologies

Several instruments utilizing different optical principles have been introduced over the past 15 years to record anatomical changes in the nerve fibre layer and optic disc for objective diagnosis and to monitor progression; the role of these in clinical practice has still to be established. The devices include digital stereoscopic cameras and scanning devices, scanning laser tomography, scanning laser polarimetry, optical coherence tomography and retinal thickness analysis. Measurements can be compared with normal ranges although the overlap between normal and glaucomatous values makes diagnosis on this basis difficult, and the devices may be more useful for detecting progressive structural change in an individual eye.

Visual function

An accurate assessment of the visual field is essential for the diagnosis and monitoring of glaucoma. Difficulty in obtaining quantifiable results with kinetic perimetry has led to automated static perimetry of the central 24–30° becoming the norm for glaucoma work as it is uncommon for glaucomatous field defects to occur elsewhere in the visual field in the absence of a defect in this area. Computerized field tests require cooperation and concentration from the patient so faster test strategies are of particular benefit. Each test is a subjective assessment of visual function and the results depend on the patient’s attention, mental ability and general health as well as physiological parameters such as pupil diameter and lens opacity. A pupil diameter of less than 2 mm may produce a generalized reduction in sensitivity, as can lens opacity. Encouragement and practice can improve the reliability of results. Recently a new test algorithm for the Humphrey perimeter, the Swedish Interactive Thresholding Algorithm (SITA), has been introduced that shortens the test time without compromising test quality.

Visual field testing techniques in chronic glaucoma may be divided into those for diagnosis and screening and those for monitoring. The former requires a level of accuracy sufficient for identifying disease, whereas the latter requires the most sensitive and reliable method available that is compatible with the patient’s skill and concentration taking into account the duration of the test, cost and availability of ancillary staff. True progression of disease must be distinguished statistically from normal fluctuations in the visual field with time. A sequence of several fields over many months is normally required before progression can be diagnosed with certainty. Because test–retest variability is high in glaucomatous fields, confirmatory tests are often required to verify true progression.

Early glaucomatous defects tend to occur as scotomata in the arcuate areas (10–15° from fixation), particularly superiorly. A nasal step may occur. With time the defects coalesce, central fixation being spared until late in the disease. Because standard perimetry is not sensitive to very early glaucomatous defects new psychophysical tests have been developed that may be more sensitive to the purported selectivity of ganglion cell damage, although none has yet entered routine clinical practice.

TREATMENT

Surgery

Fistulizing surgery such as trabeculectomy without adjunctive antiscarring therapy will lower IOP to the mid teens for at least five years in 75 per cent of patients with POAG aged over 50 years. This success rate falls considerably in certain groups: those susceptible to scarring (young, black or atopic patients, those with previous conjunctival surgery, using chronic glaucoma medication or blepharitis), and those with a damaged blood–aqueous barrier (aphakia, uveitis, rubeosis, concurrent or subsequent cataract surgery). The most favourable results are seen in patients who have surgery early in the course of the disease. Eyes at high risk of surgical failure or requiring a postoperative IOP in the low teens may be helped by peroperative antifibrotic agents such as β irradiation, 5-fluorouracil (5-FU) or mitomycin C. Nonpenetrating surgery (‘deep sclerectomy’ and ‘viscocanalostomy’) has been advocated to avoid the complications of trabeculectomy, such as early hypotony and subsequent cataract. The surgery is ‘nonpenetrating’ because a trabecular/corneal membrane is preserved after the inner wall of Schlemm’s canal and external part of the trabecular meshwork have been peeled, through which aqueous percolates. The way in which this surgery works is controversial; filtering blebs are frequent, both uveoscleral and transscleral filtration may be increased, and microperforations in the trabecular meshwork may create a gentle trabeculectomy. IOP reduction is less in comparison to trabeculectomy.

PRIMARY ANGLE CLOSURE

Primary angle closure (PAC) occurs when aqueous drainage is prevented by contact between the peripheral iris and the trabecular meshwork in the absence of other pathological processes such as iris neovascularization. In most cases the condition probably begins with intermittent and reversible appositional contact, which, if prolonged or associated with ocular inflammation, becomes synechial and irreversible from scar formation. In some cases prolonged apposition may irreversibly impair trabecular function so that even reopening the angle with pilocarpine, laser iridotomy or surgery does not restore outflow. Long-term topical pilocarpine therapy probably enhances the risk of synechial angle closure.

PAC is a major cause of glaucoma blindness worldwide. It is common among people of East Asian origin: the Inuit in Arctic regions of Alaska, Canada and Greenland are most severely affected and the Chinese are at higher risk than native South-East Asian races (Indonesian, Malay, Thai and Vietnamese). The risk of angle closure in India is lower than in China but higher than in Europeans. The relative risk of angle closure in women is two to three times higher than in men and risk increases after 30 years of age. An estimated 1.7 million people in China are blind from glaucoma; more than 90 per cent of these cases are attributed to PAC.

Recent research has highlighted significant differences in the clinical course of PAC between European and Asian people leading to a radical rethink in the way the disease is classified. In the Western world PAC has usually been recognized when the condition is acute and symptomatic, so that it has traditionally been classified by the presence or absence of symptoms: acute with unremittingly florid pain and decreased vision; intermittent with self-limiting symptoms; and chronic when asymptomatic but usually with associated past symptomatic attacks of raised IOP. However, this approach is flawed. In Asia, between 50 and 75 per cent of people with glaucomatous optic neuropathy from angle closure do not suffer the classical symptoms familiar to Western ophthalmologists. Furthermore classification by symptoms does not reflect the severity of damage to ocular tissues or visual loss and this classification does not help to guide management in individual patients. It is now widely acknowledged that the term glaucoma should be used only when glaucomatous optic neuropathy is present. The term primary angle closure (PAC) is recommended for significant angle closure but with a normal optic nerve (Table 7.6).

Table 7.6 Current classification of primary angle closure

Type Description
PAC suspect Narrow drainage angle considered to be at risk of closure
PAC Significant angle closure and raised IOP due to iridotrabecular contact or PAS not attributable to other pathology. Optic nerve considered to be unaffected by glaucoma
PACG Drainage angle closed or capable of closure accompanied by signs of glaucomatous optic neuropathy

PRIMARY ANGLE CLOSURE GLAUCOMA

Symptomatic PAC is difficult to ignore: there is dramatically reduced visual acuity, ciliary injection and pain sufficiently intense to cause nausea and vomiting. Intermittent episodes of PAC typically occur when an individual is at home engaged in sedentary past times such as reading or sewing. Symptoms are often precipitated by dim light, such as in the cinema. Impaired vision is described as milky and hazy, and like ‘looking through smoke’; multicoloured haloes are sometimes seen. However, the condition may be completely asymptomatic. Even with advanced angle closure and IOP exceeding 70 mmHg, the cornea may remain clear, and the eye white and quiet. Patients without symptoms are most at risk of severe visual loss, as they often present only when one eye is blind and the other severely glaucomatous. In patients with dark brown irides, the anterior chamber may not appear especially shallow, even if there is significant angle closure and careful gonioscopy is needed to confirm the diagnosis.

MECHANISM OF PRIMARY ANGLE CLOSURE

Identifying the mechanism responsible for angle closure is essential for effective treatment. Pupil block is responsible for 80–90 per cent of all cases. Closure may occur first at the deepest part of the angle recess (closure at the bottom of the angle) or between the midperipheral iris and Schwalbe’s line (closure at Schwalbe’s line). Differing patterns of pigment distribution on the trabecular meshwork may be seen with these two types of angle closure although their clinical course and prognosis appears similar. The lens may be involved either as a primary phenomenon, in which the lens is thicker and more anteriorly positioned than normal, or as a secondary phenomenon in which a hypermature lens swells and further shallows an already narrow chamber angle.

Non-pupil-block angle closure is an umbrella term encompassing plateau iris and peripheral iris crowding. Plateau iris configuration describes the appearance of a peripheral iris that rises from its insertion and then makes an abrupt angulation away from the corneoscleral coat at its insertion and is seen to some degree in 5–8 per cent of adults. The appearance of plateau irides varies greatly, both in the level of the plateau relative to the trabecular meshwork and in the width of the gap between iris and trabecular meshwork; these influence the risk of closure. The plateau iris syndrome describes an eye with plateau iris configuration and a patent iridotomy or iridectomy that subsequently suffers further angle closure. Peripheral iris crowding describes angle closure without pupil block and is seen on gonioscopy as a very bulky peripheral iris thrown into circumferential folds in a shallow peripheral anterior chamber to occlude the angle.

MANAGEMENT

The first priority in managing PAC, with or without optic nerve damage, is to control IOP. This is most quickly achieved by either medical or laser treatment. All classes of medical agents have a role, particularly in treating symptomatic episodes, although pilocarpine is unique in its ability to open some closed angles mechanically. Definitive treatment is surgical with either laser or conventional surgical techniques. Pure pupil-block angle closure is managed successfully by laser iridotomy or surgical iridectomy. Synechial closure of more than 180° or glaucomatous optic neuropathy usually requires a trabeculectomy. Lens related cases of PAC are treated by lens extraction. Ciliolenticular block (‘malignant glaucoma’) following trabeculectomy is a risk in eyes with very shallow anterior chambers for which combined lens extraction and trabeculectomy may be safer (see Ch. 8).

Management of eyes with the plateau iris syndrome (significant angle closure with a patent peripheral iridotomy) is contentious. Topical pilocarpine, laser iridoplasty and lens extraction may all be used, although the younger age of these patients means that lens extraction and long-term pilocarpine therapy may be inappropriate. Laser iridoplasty is potentially useful for managing both pupil block and plateau iris PAC, although its efficacy and safety remains to be proved.

CONGENITAL AND DEVELOPMENTAL GLAUCOMA

The alternative term for congenital glaucoma, buphthalmos, is derived from the Greek for ‘ox eye’ which refers to the acquired megalocornea that develops in the child with congenital glaucoma. Raised IOP in the first 18 months of life occurs at a time when the corneal collagen (and scleral collagen) is still plastic or ‘stretchable’. In the UK congenital glaucomas are very rare, but in countries where interrelated marriages are common inheritance of recessive genes considerably increases the number of cases.

Clinically congenital glaucoma presents as a group of rare heterogeneous conditions which await further developments in the understanding of genetics and development of the anterior chamber angle for true classification. The trabecular meshwork is derived from neural crest cells, and the congenital glaucomas presumably arise from dysgenesis of these cells in utero. Primary congenital glaucoma develops as a result of maldevelopment of the outflow system of the eye although the angle appears normal on gonioscopy and there are no other ocular abnormalities. It occurs as an isolated ocular defect and there is often a degree of asymmetry in the involvement of the two eyes. Idiopathic buphthalmos is more common in male infants. Secondary congenital glaucoma is associated with a wide range of other ocular and systemic abnormalities such as anterior segment dysgenesis and chromosomal abnormalities. Commonly associated systemic syndromes are neurofibromatosis or the Sturge–Weber syndrome, both of which involve neural crest cells. Rarely buphthalmos may occur as a result of peripheral anterior synechiae formation in the first 18 months of life, for example from perforating corneal ulcers.

An alternative classification is descriptive, according to the extent of the abnormality seen. There are three broad groups:

These anomalies do not inevitably produce glaucoma (the risk of glaucoma with the Axenfeld–Reiger anomaly is 50 per cent).

TREATMENT

Treatment of congenital glaucoma is primarily surgical. Goniotomy is the treatment of choice, although it is impossible when the cornea has stromal haze. It works less well if the horizontal corneal diameter exceeds 14 mm or if the child is more than 3 years of age. Trabeculotomy is an alternative to goniotomy, although the procedure violates the conjunctiva and may prejudice future trabeculectomy surgery. It is suitable for eyes with anterior segment dysgeneses or when the drainage angle cannot be visualized. Trabeculectomy is indicated in eyes with failed angle procedures and when a low target IOP needs to be achieved. An antifibrotic agent, such as β irradiation or mitomycin C, is usually required to combat the aggressive healing response in children. For severely affected eyes, cyclodestructive procedures or insertion of a silicone tube can be considered. Buphthalmic eyes can have significant refractive error, and accurate refraction and treatment of amblyopia play an important part in the successful visual outcome.

IRIDOTRABECULAR AND IRIDOCORNEOTRABECULODYSGENESIS

Posterior embryotoxon is the term given to an unusual prominence of Schwalbe’s line that rotates outwards to be seen as a white band inside the limbus. It occurs in about 15 per cent of normal people and is considered to be hyperplasia of tissue on the posterior cornea near the angle; it is of no pathological significance.

Iris strands to a prominent Schwalbe’s line are known as Axenfeld’s anomaly; if glaucoma is present, the condition is known as Axenfeld’s syndrome. Rieger reported similar cases but with additional ocular abnormalities such as microcornea, corectopia (eccentric pupils) and polycoria (multiple pupils). Extended pedigrees show considerable variation in affected family members and for this reason many authors group them together as the Axenfeld–Rieger malformation although the conditions are both genetically and phenotypically heterogeneous. Defects in FOXC1 and PITX2 may give rise to this spectrum of abnormality. The extent of abnormality may vary between individuals with the same gene mutation and different mutations can cause the same clinical appearance. These ocular features together with systemic abnormalities, such as abnormalities of the teeth and facial bones (hypertelorism), are referred to as Rieger’s syndrome. Peter’s anomaly (see Ch. 6) consists of adhesions from the iris collarette (and sometimes lens) to the posterior corneal surface which has a central opacity and stromal defect. It is usually bilateral (80% per cent) and other defects of anterior segment development may be present. Glaucoma occurs in a substantial number (50–70 per cent) of cases. The central corneal opacity often clears substantially with control of the IOP.